DK0517876T3 - Terapeutiske benzazepinforbindelser - Google Patents
Terapeutiske benzazepinforbindelserInfo
- Publication number
- DK0517876T3 DK0517876T3 DK92901758.0T DK92901758T DK0517876T3 DK 0517876 T3 DK0517876 T3 DK 0517876T3 DK 92901758 T DK92901758 T DK 92901758T DK 0517876 T3 DK0517876 T3 DK 0517876T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- therapeutic
- formula
- neurological disorders
- benzazepine compounds
- Prior art date
Links
- 150000008038 benzoazepines Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 2
- 208000025966 Neurological disease Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919100028A GB9100028D0 (en) | 1991-01-02 | 1991-01-02 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0517876T3 true DK0517876T3 (da) | 1997-04-01 |
Family
ID=10687882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92901758.0T DK0517876T3 (da) | 1991-01-02 | 1991-12-30 | Terapeutiske benzazepinforbindelser |
Country Status (22)
Country | Link |
---|---|
US (3) | US5254683A (da) |
EP (1) | EP0517876B1 (da) |
JP (1) | JP3034604B2 (da) |
KR (1) | KR100229049B1 (da) |
AT (1) | ATE144423T1 (da) |
AU (1) | AU650086B2 (da) |
CA (1) | CA2058593A1 (da) |
CZ (1) | CZ299292A3 (da) |
DE (1) | DE69122858T2 (da) |
DK (1) | DK0517876T3 (da) |
ES (1) | ES2093246T3 (da) |
FI (1) | FI104071B1 (da) |
GB (2) | GB9100028D0 (da) |
GR (1) | GR3021440T3 (da) |
HU (2) | HU212269B (da) |
IE (1) | IE920009A1 (da) |
IL (1) | IL100484A (da) |
NO (1) | NO300497B1 (da) |
NZ (1) | NZ241197A (da) |
PL (1) | PL166481B1 (da) |
WO (1) | WO1992011854A1 (da) |
ZA (1) | ZA9223B (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9100028D0 (en) * | 1991-01-02 | 1991-02-20 | Ici Plc | Compounds |
GB9212308D0 (en) * | 1992-06-10 | 1992-07-22 | Ici Plc | Therapeutic compositions |
CA2138026C (en) * | 1992-06-22 | 2003-09-09 | Eckard Weber | Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists |
US5834479A (en) * | 1993-03-05 | 1998-11-10 | Mayer; David J. | Method and composition for alleviating pain |
CA2115792C (en) | 1993-03-05 | 2005-11-01 | David J. Mayer | Method for the treatment of pain |
GB9311948D0 (en) * | 1993-06-10 | 1993-07-28 | Zeneca Ltd | Substituted nitrogen heterocycles |
US5801168A (en) * | 1994-06-09 | 1998-09-01 | Zeneca Limited | Substituted nitrogen heterocycles |
US5476933A (en) * | 1994-11-16 | 1995-12-19 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon | Azepine synthesis via a diels-alder reaction |
FR2796552A1 (fr) * | 1999-07-21 | 2001-01-26 | Centre Nat Rech Scient | Nouvelle utilisation de derives de la beta-naphtoquinone et de leurs sels pour la fabrication de medicaments exercant un effet inhibiteur sur la liberation de glutamate dans le cerveau |
JP4989830B2 (ja) * | 1999-07-21 | 2012-08-01 | サーントゥル ナシオナル ドゥ ラ ルシェルシュ シャーンティフィク | 脳によるグルタミン酸塩の放出に対して抑制効果を示す薬剤を製造するためのベータ−ナフトキノン誘導体の使用 |
JPWO2016199789A1 (ja) * | 2015-06-08 | 2018-03-29 | 国立大学法人名古屋大学 | トリフルオロメチル置換セミスクアレートの製造方法、トリフルオロメチル置換セミスクアレートを起点とするトリフルオロメチル化合物の製造方法及びトリフルオロメチル基含有化合物 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1340334A (en) * | 1970-07-06 | 1973-12-12 | Rees A H | Synthesis of benzazetropolones and hence of kynurenic acids |
EP0072352B1 (de) * | 1981-08-11 | 1986-03-05 | Ciba-Geigy Ag | Benzazepin-2-one, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese Verbindungen enthalten, sowie die Verbindungen zur therapeutischen Verwendung |
US4410520A (en) * | 1981-11-09 | 1983-10-18 | Ciba-Geigy Corporation | 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids |
US4473575A (en) * | 1982-07-19 | 1984-09-25 | Ciba-Geigy Corporation | 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids |
US4575503A (en) * | 1983-02-10 | 1986-03-11 | Ciba-Geigy Corporation | 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids |
US4477446A (en) * | 1983-07-01 | 1984-10-16 | Usv Pharmaceutical Corporation | 1-Benzazepines and their pharmaceutical uses |
DE3416695A1 (de) * | 1984-05-05 | 1985-11-07 | Bayer Ag, 5090 Leverkusen | Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
DE69026708T2 (de) * | 1989-10-20 | 1997-04-03 | Otsuka Pharma Co Ltd | Benzoheterozyklische verbindungen |
GB9100028D0 (en) * | 1991-01-02 | 1991-02-20 | Ici Plc | Compounds |
CA2138026C (en) * | 1992-06-22 | 2003-09-09 | Eckard Weber | Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists |
-
1991
- 1991-01-02 GB GB919100028A patent/GB9100028D0/en active Pending
- 1991-12-24 IL IL10048491A patent/IL100484A/xx not_active IP Right Cessation
- 1991-12-30 KR KR1019920702119A patent/KR100229049B1/ko not_active Expired - Fee Related
- 1991-12-30 DE DE69122858T patent/DE69122858T2/de not_active Expired - Fee Related
- 1991-12-30 WO PCT/GB1991/002326 patent/WO1992011854A1/en active IP Right Grant
- 1991-12-30 AU AU91340/91A patent/AU650086B2/en not_active Ceased
- 1991-12-30 PL PL91295932A patent/PL166481B1/pl unknown
- 1991-12-30 EP EP92901758A patent/EP0517876B1/en not_active Expired - Lifetime
- 1991-12-30 AT AT92901758T patent/ATE144423T1/de not_active IP Right Cessation
- 1991-12-30 DK DK92901758.0T patent/DK0517876T3/da active
- 1991-12-30 JP JP04502158A patent/JP3034604B2/ja not_active Expired - Fee Related
- 1991-12-30 HU HU9202618A patent/HU212269B/hu unknown
- 1991-12-30 CA CA002058593A patent/CA2058593A1/en not_active Abandoned
- 1991-12-30 ES ES92901758T patent/ES2093246T3/es not_active Expired - Lifetime
- 1991-12-30 GB GB9127498A patent/GB2251616B/en not_active Expired - Fee Related
- 1991-12-31 US US07/816,327 patent/US5254683A/en not_active Expired - Fee Related
-
1992
- 1992-01-02 IE IE000992A patent/IE920009A1/en not_active IP Right Cessation
- 1992-01-02 ZA ZA9223A patent/ZA9223B/xx unknown
- 1992-01-06 NZ NZ241197A patent/NZ241197A/en unknown
- 1992-08-20 FI FI923759A patent/FI104071B1/fi active
- 1992-09-01 NO NO923413A patent/NO300497B1/no not_active IP Right Cessation
- 1992-09-30 CZ CS922992A patent/CZ299292A3/cs unknown
-
1993
- 1993-07-23 US US08/096,795 patent/US5446039A/en not_active Expired - Lifetime
-
1995
- 1995-05-01 US US08/431,809 patent/US5541319A/en not_active Expired - Fee Related
- 1995-06-26 HU HU95P/P00441P patent/HU211466A9/hu unknown
-
1996
- 1996-10-24 GR GR960402536T patent/GR3021440T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY109737A (en) | Treatment and compounds. | |
ATE8874T1 (de) | Therapeutisch nuetzliche 1-alkyl-2-amino-tetralin- derivate. | |
FI961914A0 (fi) | Lyhytvaikutteiset dihydropyridiinit | |
DK0517876T3 (da) | Terapeutiske benzazepinforbindelser | |
NO923199D0 (no) | Terapeutiske forbindelser | |
DK0510748T3 (da) | Anvendelse af en methoxyalkansyre af indazol til fremstilling af et lægemiddel til behandling af autoimmune sygdomme | |
ATE5961T1 (de) | N-acylpeptid-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
IE832680L (en) | Nitrosourea derivatives. | |
FI923662A0 (fi) | Terapeutiska medel. | |
IL101506A0 (en) | Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients | |
MY108455A (en) | Therapeutic benzazapine compounds. | |
PT100641A (pt) | Processo de tratamento com benzazepinas, composicoes farmaceuticas que contem estas benzazepinas, compostos benzazepinicos e processo para a sua preparacao | |
HU894471D0 (en) | Process for the preparation of 15-amino-20,21-dinor-eburnamenine derivatives and pharmaceutical compositions containing them | |
HK34095A (en) | Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases |